Logos Global Management LP, 10% Owner at Novus Therapeutics, Inc. (NVUS), bought 114,080 shares at $24.03 ($2.9M) on 2020-10-30, disclosed to the SEC on 2020-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.03 | 5,000 | $120K | 4.1% |
| 2 | $24.53 | 31,000 | $760K | 26.1% |
| 3 | $25.55 | 9,098 | $232K | 8.0% |
| 4 | $25.55 | 9,098 | $232K | 8.0% |
| 5 | $25.88 | 12,942 | $335K | 11.5% |
| 6 | $25.88 | 12,942 |
| $335K |
| 11.5% |
| 7 | $25.97 | 4,000 | $104K | 3.6% |
| 8 | $26.17 | 15,000 | $393K | 13.5% |
| 9 | $26.48 | 15,000 | $397K | 13.7% |
| Total | $25.50 avg | 114,080 | $2.9M | 100% |
| Filing → |